<?xml version="1.0" encoding="UTF-8"?>
<ref id="B152">
 <label>152.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Alberer</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Gnad-Vogt</surname>
    <given-names>U</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>HS</given-names>
   </name>
   <name>
    <surname>Mehr</surname>
    <given-names>KT</given-names>
   </name>
   <name>
    <surname>Backert</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Finak</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial</article-title>. 
  <source>Lancet</source> (
  <year>2017</year>) 
  <volume>390</volume>:
  <fpage>1511</fpage>â€“
  <lpage>20</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0140-6736(17)31665-3</pub-id>
  <?supplied-pmid 28754494?>
  <pub-id pub-id-type="pmid">28754494</pub-id>
 </mixed-citation>
</ref>
